Navigation Links
Brain cell transplants win Fernström Prize

This year's Fernstrm Foundation Nordic Prize, with prize money of SEK 1 million, goes to Professor Anders Bjrklund from Lund University, Sweden. He is a neurology researcher focusing on neurodegenerative diseases, diseases in which the nerve cells die. Professor Bjrklund's research group is trying to develop customised stem cells to treat Parkinson's disease.

Shipowner Eric K. Fernstrm's foundation is based at the Faculty of Medicine at Lund University. The Foundation awards an annual Nordic prize of SEK 1 million and local prizes of SEK 100 000 each to promising young researchers at Sweden's six university medical faculties.

This year's prize recognises Anders Bjrklund's "development of innovative forms of treatment for Parkinson's disease". The work began in the 1970s, when his research group were pioneers in transplanting new nerve cells into the brain. At the time, most researchers did not consider this either possible or meaningful.

"The prevailing view was that the brain was a sort of switchboard, a closed control room that couldn't be changed. Now, on the other hand, we know that the brain is plastic it changes all the time depending on the individual's development and possible diseases", says Anders Bjrklund.

The transplantation of brain cells has grown into a major international research field. In Lund, a number of patients with Parkinson's disease have received nerve cell transplants. However, the results have been mixed: some patients have seen a marked improvement, while others have not been affected at all. The fetal brain cells used in these trials are difficult to obtain in sufficiently large numbers, and too varied in quality to form the basis for a more regular treatment.

Hope is therefore in stem cells which are customised to produce dopamine, the substance which Parkinson's patients lack. The vision is to halt the progression of the disease at an early stage through a one-off treatment with these stem cells.

"This requires a surgical operation on the brain, of course. However, such operations have already been performed on many thousands of Parkinson's patients, for whom medication has not worked and who instead have received 'deep brain stimulation' via an electrode. The stem cells could be injected in a similar way via thin cannulas to different parts of the brain", explains Anders Bjrklund.

First, however, suitable stem cells must be developed and tested. The large research network around Anders Bjrklund is actively involved in this work. The aim is both to develop cells which function as planned without the risk of side-effects and to work out which patients benefit from the treatment.

"We believe that only a subgroup of Parkinsonpatients can benefit from receiving new dopamine-producing cells. We need to understand what characterises this group so that we don't subject any patients to an unnecessary procedure", says Anders Bjrklund.

However, he has a strong belief in the method.

"If we can show that a transplant of healthy nerve cells can help a brain damaged by Parkinson's disease to heal itself, then that principle could also be used for other neurological diseases", he says.


Contact: Professor Anders Bjrklund
Lund University

Related medicine news :

1. New X-Rays Offer Clues on Evolution of the Human Brain
2. Stroke prevention trial finds intensive medical treatment has better results than brain stenting
3. Bilingual Homes Help Babies Exercise Their Brain: Study
4. Control of fear in the brain decoded
5. Brain Scans Show Distinct Traits in Kids With Autism: Study
6. Old-Age Tremors May Be Caused by Brain Lesions
7. Alzheimers brains found to have lower levels of key protein
8. Alcohol dulls brain alarm that monitors mistakes, MU study finds
9. Use Caution in Ending Life Support for Brain-Injured, Experts Say
10. Learning information the hard way may be best boot camp for older brains
11. Brain tumors found to have a 2-tier system
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... An ... directory is specialized and only includes chiropractic clinics in the US. , The ... trustworthy alternative health practitioner when back pain sets in. When people are experiencing ...
(Date:11/30/2015)... ... November 30, 2015 , ... In ... Halloween festivities, the Word of Life Christian Church of Flint, MI, hosted a ... a giant 1.25 ton pile of candy dubbed “Candy Mountain”. , A Forever ...
(Date:11/30/2015)... ... November 30, 2015 , ... During ... fundraising campaign to raise funds for its research, education, support, and advocacy efforts. ... organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes by ...
(Date:11/30/2015)... ... November 30, 2015 , ... The ... in Dallas, TX, on January 29 and 30, 2016. The course welcomes dental ... of their practices, to learn how to better succeed in the modern dental ...
(Date:11/30/2015)... ... November 30, 2015 , ... HemoTreat™ has announced that the ... ointment to its website. , “Our goal is simple:” says Michael Blasco, HemoTreat’s ... the comparison chart and ingredient list allows our customers to quickly see why, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... Free Press as a Top Workplace , among the ... work for in 2015. ... annually, based on employee surveys rating company leadership, career opportunities, ... based solely on employee feedback. The survey is conducted by ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: